Skip to main content
Top
Published in: Abdominal Radiology 5/2008

01-09-2008

Peritumoral steatosis associated with insulinomas: appearance at imaging

Authors: Thomas D. Atwell, Ricardo V. Lloyd, David M. Nagorney, Jeff L. Fidler, James C. Andrews, Carl C. Reading

Published in: Abdominal Radiology | Issue 5/2008

Login to get access

Abstract

We report three patients with insulinoma tumors and distinct peritumoral steatosis, well demonstrated with several imaging modalities. This unique appearance can aid in pre-operative diagnosis and guide biopsy.
Literature
1.
go back to reference Service FJ, et al. (1991) Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7):711–719PubMed Service FJ, et al. (1991) Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7):711–719PubMed
2.
go back to reference Brentjens R, Saltz L (2001) Islet cell tumors of the pancreas: the medical oncologist’s perspective. Surg Clin North Am 81(3):527–542PubMedCrossRef Brentjens R, Saltz L (2001) Islet cell tumors of the pancreas: the medical oncologist’s perspective. Surg Clin North Am 81(3):527–542PubMedCrossRef
3.
go back to reference Fidler JL, et al. (2003) Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol 181(3):775–780PubMed Fidler JL, et al. (2003) Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol 181(3):775–780PubMed
4.
go back to reference Herwick S, Miller FH, Keppke AL (2006) MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol 187(5):W472–W480PubMedCrossRef Herwick S, Miller FH, Keppke AL (2006) MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol 187(5):W472–W480PubMedCrossRef
5.
go back to reference Hirshberg B, et al. (2005) Malignant insulinoma: spectrum of unusual clinical features. Cancer 104(2):264–272PubMedCrossRef Hirshberg B, et al. (2005) Malignant insulinoma: spectrum of unusual clinical features. Cancer 104(2):264–272PubMedCrossRef
6.
go back to reference Hashimoto LA, Walsh RM (1999) Preoperative localization of insulinomas is not necessary. J Am Coll Surg 189(4):368–373PubMedCrossRef Hashimoto LA, Walsh RM (1999) Preoperative localization of insulinomas is not necessary. J Am Coll Surg 189(4):368–373PubMedCrossRef
7.
go back to reference Dromain C, et al. (2003) MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. AJR Am J Roentgenol 180(1):121–128PubMed Dromain C, et al. (2003) MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. AJR Am J Roentgenol 180(1):121–128PubMed
8.
go back to reference Topping DL, Mayes PA (1972) The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem J 126(2):295–311 Topping DL, Mayes PA (1972) The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem J 126(2):295–311
9.
go back to reference Eriguchi N, et al. (2000) Insulinoma occurring in association with fatty replacement of unknown etiology in the pancreas: report of a case. Surg Today 30(10):937–941PubMedCrossRef Eriguchi N, et al. (2000) Insulinoma occurring in association with fatty replacement of unknown etiology in the pancreas: report of a case. Surg Today 30(10):937–941PubMedCrossRef
10.
go back to reference Hoshiba K, et al. (1997) Fatty infiltration of the liver distal to a metastatic liver tumor. Abdom Imaging 22(5):496–498PubMedCrossRef Hoshiba K, et al. (1997) Fatty infiltration of the liver distal to a metastatic liver tumor. Abdom Imaging 22(5):496–498PubMedCrossRef
11.
go back to reference Sumiyoshi S, et al. (2005) Images of interest. Hepatobiliary and pancreatic: insulinoma metastases with focal hepatic steatosis. J Gastroenterol Hepatol 20(4):650PubMedCrossRef Sumiyoshi S, et al. (2005) Images of interest. Hepatobiliary and pancreatic: insulinoma metastases with focal hepatic steatosis. J Gastroenterol Hepatol 20(4):650PubMedCrossRef
12.
go back to reference Sohn J, Siegelman E, Osiason A (2001) Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 176(2):471–474PubMed Sohn J, Siegelman E, Osiason A (2001) Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 176(2):471–474PubMed
13.
go back to reference Fregeville A, et al. (2005) Metastatic insulinoma and glucagonoma from the pancreas responsible for specific peritumoral patterns of hepatic steatosis secondary to local effects of insulin and glucagon on hepatocytes. Gastroenterology 129(4):1150–1365PubMedCrossRef Fregeville A, et al. (2005) Metastatic insulinoma and glucagonoma from the pancreas responsible for specific peritumoral patterns of hepatic steatosis secondary to local effects of insulin and glucagon on hepatocytes. Gastroenterology 129(4):1150–1365PubMedCrossRef
14.
go back to reference Khalili K, et al. (2003) Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence. AJR Am J Roentgenol 180(6):1601–1604PubMed Khalili K, et al. (2003) Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence. AJR Am J Roentgenol 180(6):1601–1604PubMed
Metadata
Title
Peritumoral steatosis associated with insulinomas: appearance at imaging
Authors
Thomas D. Atwell
Ricardo V. Lloyd
David M. Nagorney
Jeff L. Fidler
James C. Andrews
Carl C. Reading
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 5/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9278-1

Other articles of this Issue 5/2008

Abdominal Radiology 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.